Shares of DermTech (DMTK) Risen 186% Over A Month

After announcing that its test had earned insurance coverage, the shares of biotech firm DermTech, Inc. (DMTK) started rising last month. The rally is still going on as the stock has added more than 186% over one month. . Now the business can depend on market growth, as with the DermTech Pigmented Lesion Assay (PLA) genomic test, more patients will be able to afford to test.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.


For PLA studies, the American insurance provider Geisinger Health System has approved medical insurance payments. Such studies are the newest early warning technology for melanoma (skin cancer). Its particularity is high precision: at an early stage, the risk of losing cancer is less than 1 percent. This is particularly important for this condition, as timely diagnosis decreases the risk of a dangerous course of the disease. Early disease identification systems are being implemented in certain countries’ health services as the most reliable means of sustaining health and reducing costs.

Naturally, the announcement of the introduction of DermTech technology became the engine of price rise of the stock as it has risen 27% on December 30 session. In the US health insurance market, Geisinger is one of the participants. Geisinger’s case, however, can contribute to a sequence of similar choices by other insurers. The fact that the PLA test was historically approved for reimbursement by Illinois insurance providers Blue Cross Blue Shield and California Blue Shield is in favor of this.

What effect Geisinger’s acceptance would have on the financial results of DermTech is not yet apparent. In February 2021, the organization expects to issue the next update (for the fourth quarter).

At the January 15 trading, DermTech, Inc. (DMTK) was down -1.69% to $39. The capitalization of the market now stands at $945 million


The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...

Future Prospects Brighter For Red Cat Holdings Inc. (RCAT) Stock

The US Army has awarded Red Cat Holdings, Inc....



Don't miss

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

Farmmi, Inc. (FAMI) Stock Soaring in Premarket, Here’s the Reason

Farmmi, Inc. (FAMI), a company that processes and sells...

Ulta Beauty Inc. (ULTA) last month performance of -6.16% certainly makes it a sizzling prospect

Ulta Beauty Inc. (NASDAQ: ULTA) open the trading on May 26, 2022, with great promise as it jumped 7.09% to $377.96. During the day,...

The key reasons why Alset EHome International Inc. (AEI) is -95.54% away from 52-week high?

Witnessing the stock’s movement on the chart, on May 26, 2022, Alset EHome International Inc. (NASDAQ: AEI) set off with pace as it heaved...

StoneCo Ltd. (STNE) latest performance of 2.97% is not what was on cards

StoneCo Ltd. (NASDAQ: STNE) established initial surge of 2.97% at $9.71, as the Stock market unbolted on May 26, 2022. During the day, the...


Please enter your comment!
Please enter your name here